Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Medtronic
US Army
Boehringer Ingelheim
Baxter
Colorcon

Generated: August 24, 2019

DrugPatentWatch Database Preview

Patent: 6,284,491

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,284,491
Title: Biologically active synthetic thyrotropin and cloned gene for producing same
Abstract:Substantially pure recombinant TSH has been prepared from a clone comprising complete nucleotide sequence for the expression of the TSH. Diagnostic and therapeutic applications of the synthetic TSH are described.
Inventor(s): Wondisford; Fredric E (Rockville, MD), Weintraub; Bruce D. (Rockville, MD)
Assignee: The United States of America as represented by the Department of Health and Human Services (Washington, DC)
Application Number:09/569,141
Patent Claims:see list of patent claims

Details for Patent 6,284,491

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Schering INTRON A interferon alfa-2b VIAL 103132 003 1986-06-04 ➤ Sign Up The United States of America as represented by the Department of Health and Human Services (Washington, DC) 2009-01-11 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 002 1986-06-04 ➤ Sign Up The United States of America as represented by the Department of Health and Human Services (Washington, DC) 2009-01-11 RX search
Schering INTRON A interferon alfa-2b VIAL 103132 001 1986-06-04 ➤ Sign Up The United States of America as represented by the Department of Health and Human Services (Washington, DC) 2009-01-11 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Mallinckrodt
Cipla
Deloitte
Merck
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.